CONMED Corp. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€106.18
Performance (%)
-13.31%
Price
02.05.24
€63.00
Summary
This prediction is currently active. The prediction for CONMED Corp. disappoints with a performance of -13.31%. Dividends of €0.18 are taken into consideration when calculating the performance. This prediction currently runs until 01.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
CONMED Corp. | 9.565% | 9.565% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat